{"url_path":"/sec/lfst/8-k/2026-05-12/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-12","source_url":"https://www.sec.gov/Archives/edgar/data/1845257/0001193125-26-219669-index.html","accession_number":"0001193125-26-219669","cik":"0001845257","ticker":"LFST","issuer_name":"LifeStance Health Group, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1845257/0001193125-26-219669-index.html","primary_entity_key":"0001845257","primary_entity_name":"LifeStance Health Group, Inc."},"word_count":107,"has_tables":true,"body_markdown":"Item 9.01\n\nFinancial Statements and Exhibits.\n\n(d) Exhibits\n\n \n\nExhibit\n  \nDescription\n\n 1.1\n  \n[Underwriting Agreement, dated May 7, 2026, by and among the Company, the Underwriter and the Selling Stockholders.](d107883dex11.htm)\n\n 5.1\n  \n[Opinion of Ropes & Gray LLP](d107883dex51.htm)\n\n23.1\n  \n[Consent of Ropes & Gray LLP (included in Exhibit 5.1 above)](d107883dex51.htm)\n\n104\n  \nCover Page Interactive Data File (embedded within the Inline XBRL document).\n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \n\n \nLifeStance Health Group, Inc.\n\nDate: May 12, 2026\n \n\n \nBy:\n \n\n/s/ Ryan McGroarty\n\n \n \n \n \n \n \nRyan McGroarty\n\n \n\n \n\n \nChief Financial Officer"}